Publications by authors named "Javier Jimenez Quintero"
J Bras Nefrol
November 2024
Article Synopsis
- GLP1 receptor agonists (GLP1-RAs) are medications that mimic the incretin hormone GLP1, first used for diabetes in 2005 and for obesity in 2014.
- Recent studies suggest that GLP1-RAs may also help slow kidney disease progression, leading to the Flow study, which examined semaglutide's effects.
- The Flow study confirmed semaglutide's benefits on kidney health, but the exact mechanisms of how GLP1-RAs affect renal function remain unclear, necessitating further research.
